Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2021 Apr 3

PMID 33802331

Citations 17

Authors

Gagan Chhabra

Chandra K Singh

Deeba Amiri

Neha Akula

Nihal Ahmad

Affiliations

Soon will be listed here.

Abstract

Immunomodulation of the tumor microenvironment is emerging as an important area of research for the treatment of cancer patients. Several synthetic and natural agents are being investigated for their ability to enhance the immunogenic responses of immune cells present in the tumor microenvironment to impede tumor cell growth and dissemination. Among them, resveratrol, a stilbenoid found in red grapes and many other natural sources, has been studied extensively. Importantly, resveratrol has been shown to possess activity against various human diseases, including cancer. Mechanistically, resveratrol has been shown to regulate an array of signaling pathways and processes involving oxidative stress, inflammation, apoptosis, and several anticancer effects. Furthermore, recent research suggests that resveratrol can regulate various cellular signaling events including immune cell regulation, cytokines/chemokines secretion, and the expression of several other immune-related genes. In this review, we have summarized recent findings on resveratrol's effects on immune regulatory cells and associated signaling in various cancer types. Numerous immunomodulatory effects of resveratrol suggest it may be useful in combination with other cancer therapies including immunotherapy for effective cancer management.

Citing Articles

Resveratrol: potential application in safeguarding testicular health.

Zhang X, Yi R, Liu Y, Ma J, Xu J, Tian Q EPMA J. 2024; 15(4):643-657.

PMID: 39635023 PMC: 11612077. DOI: 10.1007/s13167-024-00377-1.

Potential Strategies for Overcoming Drug Resistance Pathways Using Propolis and Its Polyphenolic/Flavonoid Compounds in Combination with Chemotherapy and Radiotherapy.

Orsolic N, Jazvinscak Jembrek M Nutrients. 2024; 16(21).

PMID: 39519572 PMC: 11547968. DOI: 10.3390/nu16213741.

Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy.

Ghemrawi R, Abuamer L, Kremesh S, Hussien G, Ahmed R, Mousa W Biomedicines. 2024; 12(9).

PMID: 39335671 PMC: 11429153. DOI: 10.3390/biomedicines12092158.

Resveratrol and its analogs suppress HIV replication, oxidative stress, and inflammation in macrophages.

Kumar S, Sinha N, Kodidela S, Godse S, Singla B, Singh U NeuroImmune Pharm Ther. 2023; 2(4):365-374.

PMID: 38058997 PMC: 10696571. DOI: 10.1515/nipt-2023-0012.

Resveratrol induces major histocompatibility complex class I antigen presentation in a STING-dependent and independent manner in melanoma.

Morehead L, Koss B, Fil D, Heflin B, Garg S, Wallis K Mol Immunol. 2023; 163:188-195.

PMID: 37837954 PMC: 10792541. DOI: 10.1016/j.molimm.2023.10.003.

References

Sinha D, Sarkar N, Biswas J, Bishayee A . Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms. Semin Cancer Biol. 2016; 40-41:209-232. DOI: 10.1016/j.semcancer.2015.11.001. View

Kim J, Jeong S, Oh S, Lee C, Kang Y, Jo W . The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth. Int J Oncol. 2020; 56(6):1405-1416. PMC: 7170036. DOI: 10.3892/ijo.2020.5017. View

Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M . Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. 2020; 18(1):59. PMC: 7140346. DOI: 10.1186/s12964-020-0530-4. View

Hasan M, Bae H . An Overview of Stress-Induced Resveratrol Synthesis in Grapes: Perspectives for Resveratrol-Enriched Grape Products. Molecules. 2017; 22(2). PMC: 6155908. DOI: 10.3390/molecules22020294. View

Alarcon de La Lastra C, Villegas I . Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans. 2007; 35(Pt 5):1156-60. DOI: 10.1042/BST0351156. View

Jang M, Cai L, Udeani G, Slowing K, Thomas C, Beecher C . Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997; 275(5297):218-20. DOI: 10.1126/science.275.5297.218. View

Gardner A, Ruffell B . Dendritic Cells and Cancer Immunity. Trends Immunol. 2016; 37(12):855-865. PMC: 5135568. DOI: 10.1016/j.it.2016.09.006. View

Franklin R, Liao W, Sarkar A, Kim M, Bivona M, Liu K . The cellular and molecular origin of tumor-associated macrophages. Science. 2014; 344(6186):921-5. PMC: 4204732. DOI: 10.1126/science.1252510. View

Jeong M, Yang K, Choi Y, Kim S, Yoo Y, Seo S . Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+CD25+ regulatory T cells in FM3A tumor bearing mice. Int Immunopharmacol. 2012; 14(3):328-33. DOI: 10.1016/j.intimp.2012.07.018. View

10.

Fei X, Wang A, Wang D, Meng X, Ma J, Hong L . Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol. BMC Immunol. 2018; 19(1):7. PMC: 5796576. DOI: 10.1186/s12865-018-0246-z. View

11.

Aziz M, Kumar R, Ahmad N . Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol. 2003; 23(1):17-28. View

12.

Lee Y, Shin H, Kim J . In vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation. J Innate Immun. 2020; 13(2):94-106. PMC: 8077674. DOI: 10.1159/000510315. View

13.

Hadi S, Ullah M, Azmi A, Ahmad A, Shamim U, Zubair H . Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer. Pharm Res. 2010; 27(6):979-88. DOI: 10.1007/s11095-010-0055-4. View

14.

Jung-Hynes B, Schmit T, Reagan-Shaw S, Siddiqui I, Mukhtar H, Ahmad N . Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. J Pineal Res. 2010; 50(2):140-9. PMC: 3052633. DOI: 10.1111/j.1600-079X.2010.00823.x. View

15.

Lin H, Tang H, Davis F, Davis P . Resveratrol and apoptosis. Ann N Y Acad Sci. 2011; 1215:79-88. DOI: 10.1111/j.1749-6632.2010.05846.x. View

16.

Yang M, Li Z, Tao J, Hu H, Li Z, Zhang Z . Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells. J Cancer Res Clin Oncol. 2021; 147(4):1101-1113. PMC: 7954741. DOI: 10.1007/s00432-021-03510-z. View

17.

Singh C, George J, Ahmad N . Resveratrol-based combinatorial strategies for cancer management. Ann N Y Acad Sci. 2013; 1290:113-21. PMC: 3713511. DOI: 10.1111/nyas.12160. View

18.

Cecchinato V, Chiaramonte R, Nizzardo M, Cristofaro B, Basile A, Sherbet G . Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem Pharmacol. 2007; 74(11):1568-74. DOI: 10.1016/j.bcp.2007.08.001. View

19.

Hsieh T, Lu X, Wang Z, Wu J . Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Med Chem. 2006; 2(3):275-85. DOI: 10.2174/157340606776930709. View

20.

Rafe T, Shawon P, Salem L, Chowdhury N, Kabir F, Bin Zahur S . Preventive Role of Resveratrol Against Inflammatory Cytokines and Related Diseases. Curr Pharm Des. 2019; 25(12):1345-1371. DOI: 10.2174/1381612825666190410153307. View